Getting to Know Hayes: Mary McCabe Paine, RN, MPhil, DHSc, Director of Clinical Services

Posted by The Evidence Blog on March 23, 2017

Hayes is a company of real people. We’d like you to get to know us and the ways we strive to provide personalized service to you, our clients. This month, let us introduce you to another valuable contributor to the Hayes mission of providing fiercely unbiased evidence, and a leader in the concept of delighting clients. Meet Dr. Mary McCabe Paine.

Dr. Paine joined Hayes in February 2017 as Director of Clinical Services. She is tasked with providing leadership and oversight of the Clinical Research Support (CRS) and Client Services teams who play a primary role in responding to the ad hoc research needs of all of our subscribers, as well as providing educational services and new-user orientation. Additionally, Mary oversees production of the Clinical Research Response (CRR) and Search & Summary product lines.

Read More

Topics: Hayes Blog, Healthcare Evidence

Tips for Supply Chain to Improve Physician Buy-In. Part 4 of 4.

Posted by David Zieve, MD, MHA, Medical Director on March 22, 2017

We’ve reached the final stretch of our physician engagement blog. Thanks for sticking with us! By now, we hope you’ve already applied some of our suggestions as to how to improve your physician buy-in. Don’t forget to share this blog with your supply chain and value analysis peers as well as the physicians in your hospital or health system. While you’re here, download our companion eBook for a lighthearted look at the challenges of physician engagement. Who couldn’t use a good laugh?

Let’s wrap up part 4 with our final piece of advice!

Read More

Topics: Hospitals, Hayes Blog, Health Technology Assessments,

Approaches to Genetic Testing: Somatic vs Germline

Not all genetic tests are created equal. It’s a fact that applies not only to quality, but also to the information that the test reveals. Therefore, it is important to ask: should all genetic tests be assessed the same way? The answer is not a simple “yes” or “no,” but rather the question demands a closer look at the types of variants (changes in the DNA or other biomarkers) the test is assessing. This week, we will highlight the key differences between germline and somatic variants and the implications for tests that examine each.

Read More

Topics: Hayes Blog, Genetic Testing, Health Technology Assessments,

Does Evidence Have a Role in Treating the Opioid Epidemic?

America has an opioid problem.

According to a 2016 report from the American Society of Addiction Medicine (ASAM), drug overdose is the leading cause of accidental death in the U.S., with 52,404 lethal drug overdoses in 2015. Of that number, 20,101 overdose deaths were related to prescription opioid pain relievers and 12,990 overdose deaths were related to heroin in 2015. In 2012, 259 million prescriptions were written for opioids; 80% of new heroin users began by misusing prescription painkillers. 

Read More

Topics: Health Technologies, Payers, Hospitals, Hayes Blog

New Methodology Webinar Focuses on Supply Chain and Value Analysis

Despite the possibility of impending changes to current healthcare regulations, it appears, at least for the moment, that value-based purchasing and bundled payment plans are here to stay. As a result, hospitals and health systems must scrutinize their decision-making processes around health technology acquisitions, product standardization, and utilization management. As part of that process, it is incumbent upon both supply chain/value analysis professionals and clinicians to consider three important questions:

Read More

Topics: Hospitals, Hayes Blog, Health Technology Assessments,

Big Data, MACRA, and Evidence: What’s the link?

By now, it’s probably safe to say that some, if not all, of you have experienced some level of “big data fatigue.” The phrase has become ubiquitous, no matter the industry, although it seems none more so than in healthcare. Indeed, almost every healthcare news source to which I subscribe these days seems to have weekly articles, essays, white papers and blogs about big data. But there’s a common thread often missing from these reports. While they all report on the inevitability of big data’s influence on the healthcare sphere, as well as the manner in which electronic health/medical records (EHR/EMR) will continue to impact the future of care delivery, there is little discussion of the role of evidence as it relates to big data.

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence, Medicare

There Are No Alternative Facts About Evidence-Based Medicine

Posted by The Evidence Blog on March 10, 2017

It’s been quite a week for American healthcare.

The current administration unveiled the first phase of their proposal to “repeal and replace” the Patient Protection and Affordable Care Act (ACA), currently titled the American Health Care Act (AHCA). The reveal has caused no end of concerns for patients, providers, and insurance carriers.

Read More

Innovation at Hayes Begins with Our Clients

Posted by Marco Angeli, Innovation Product Owner on March 9, 2017

“When you are finished changing, you are finished.”

—Benjamin Franklin

Companies that don’t change can have the worst possible thing happen to them: they will stay in one place. It’s not unusual to fear change, but those businesses that don’t embrace it will see their competitors surpass them while their customers leave them in a steady stream.

This isn’t to say that a headlong rush into change for change’s sake is a sound strategy. Too often, companies assume they know what their customers’ needs are and begin costly and time-consuming product development without the necessary due diligence. Often what results are failed launches, lost resources, and time with no return on investment, and worst of all, unhappy customers with a solution they might never have needed.

Read More

Topics: Hayes Blog

Tips for Supply Chain to Improve Physician Buy-In: Part 3 of 4

Posted by David Zieve, MD, MHA, Medical Director on March 7, 2017

Back for more? Great! We hope these tips are proving helpful in improving your physician buy-in. If so, please share this blog with your supply chain and value analysis peers who might also be experiencing your struggles. If you haven’t already, download the companion eBook for a lighthearted look at the challenges of physician engagement.

On to part 3!

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence

Evidence: We Set the Gold Standard

Posted by The Evidence Blog on March 1, 2017

We’ve been seeing some talk out there about the “gold standard” when it comes to evidence assessment. Some seem to believe they’re the only ones that provide it. But when it comes right down to it, all that is…is talk.

It’s not just enough to say you use the “gold standard” for evidence assessment. You have to define it. You have to live it. You have to embody it.

 Hayes does.

Read More

Topics: Hayes Blog, Healthcare Evidence, Health Technology Assessments,